Exicure (XCUR) EBT Margin (2016 - 2024)
Exicure (XCUR) reported EBT Margin of 165.8% for Q1 2024, down 294.04% quarter-over-quarter from 85.45% in Q4 2022.
Exicure (XCUR) EBT Margin (2016 - 2024) Analysis & Trends
Exicure has reported EBT Margin for 8 years, with the latest figure at 165.8% in Q1 2024.
- For the quarter ending Q1 2024, EBT Margin changed N/A year-over-year to 165.8%; the trailing twelve-month figure through Dec 2024 stood at 1938.6% (changed N/A YoY), and the FY2024 full-year result was 1938.6%, changed N/A from the prior year.
- EBT Margin for Q1 2024 stood at 165.8%, down from 85.45% in the prior quarter.
- The five-year high for EBT Margin was 652.74% in Q4 2021, with the low at 18062.03% in Q2 2021.
- Historically, EBT Margin has averaged 2289.46% across 4 years, with a median of 302.31% in 2022.
- Annual changes were most pronounced in 2020 — EBT Margin soared 2305252 bps — and 2021, when it slumped 1797308 bps.
- Exicure's EBT Margin stood at 9060.71% in 2020, then surged by 107 bps to 652.74% in 2021, then sank by 87 bps to 85.45% in 2022, then plunged by 294 bps to 165.8% in 2024.
- The last three EBT Margin figures came in at 165.8% (Q1 2024), 85.45% (Q4 2022), and 255.95% (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -165.80% |
| Dec 31, 2022 | 85.45% |
| Sep 30, 2022 | -255.95% |
| Jun 30, 2022 | -302.31% |
| Mar 31, 2022 | -325.46% |
| Dec 31, 2021 | 652.74% |
| Sep 30, 2021 | -639.95% |
| Jun 30, 2021 | -18,062.03% |
| Mar 31, 2021 | -1,251.45% |
| Dec 31, 2020 | -9,060.71% |
| Sep 30, 2020 | -361.11% |
| Jun 30, 2020 | -88.94% |
| Mar 31, 2020 | 12.52% |
| Dec 31, 2019 | -3,150.32% |
| Sep 30, 2019 | -1,166.60% |
| Jun 30, 2019 | -1,194.93% |
| Mar 31, 2019 | -23,040.00% |
| Dec 31, 2018 | -84,050.00% |
| Sep 30, 2018 | -10,584.21% |
| Jun 30, 2018 | -31,421.05% |